Literature DB >> 16171294

Practice parameters for the indications for polysomnography and related procedures: an update for 2005.

Clete A Kushida1, Michael R Littner, Timothy Morgenthaler, Cathy A Alessi, Dennis Bailey, Jack Coleman, Leah Friedman, Max Hirshkowitz, Sheldon Kapen, Milton Kramer, Teofilo Lee-Chiong, Daniel L Loube, Judith Owens, Jeffrey P Pancer, Merrill Wise.   

Abstract

These practice parameters are an update of the previously-published recommendations regarding the indications for polysomnography and related procedures in the diagnosis of sleep disorders. Diagnostic categories include the following: sleep related breathing disorders, other respiratory disorders, narcolepsy, parasomnias, sleep related seizure disorders, restless legs syndrome, periodic limb movement sleep disorder, depression with insomnia, and circadian rhythm sleep disorders. Polysomnography is routinely indicated for the diagnosis of sleep related breathing disorders; for continuous positive airway pressure (CPAP) titration in patients with sleep related breathing disorders; for the assessment of treatment results in some cases; with a multiple sleep latency test in the evaluation of suspected narcolepsy; in evaluating sleep related behaviors that are violent or otherwise potentially injurious to the patient or others; and in certain atypical or unusual parasomnias. Polysomnography may be indicated in patients with neuromuscular disorders and sleep related symptoms; to assist in the diagnosis of paroxysmal arousals or other sleep disruptions thought to be seizure related; in a presumed parasomnia or sleep related seizure disorder that does not respond to conventional therapy; or when there is a strong clinical suspicion of periodic limb movement sleep disorder. Polysomnography is not routinely indicated to diagnose chronic lung disease; in cases of typical, uncomplicated, and noninjurious parasomnias when the diagnosis is clearly delineated; for patients with seizures who have no specific complaints consistent with a sleep disorder; to diagnose or treat restless legs syndrome; for the diagnosis of circadian rhythm sleep disorders; or to establish a diagnosis of depression.

Entities:  

Mesh:

Year:  2005        PMID: 16171294     DOI: 10.1093/sleep/28.4.499

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  375 in total

1.  Sleep disturbances and adverse driving events in a predominantly male cohort of active older drivers.

Authors:  Carlos A Vaz Fragoso; Katy L B Araujo; Peter H Van Ness; Richard A Marottoli
Journal:  J Am Geriatr Soc       Date:  2010-10       Impact factor: 5.562

2.  The assessment, diagnosis, and treatment of excessive sleepiness: practical considerations for the psychiatrist.

Authors:  Dewey McWhirter; Charles Bae; Kumaraswamy Budur
Journal:  Psychiatry (Edgmont)       Date:  2007-09

3.  All night analysis of time interval between snores in subjects with sleep apnea hypopnea syndrome.

Authors:  J Mesquita; J Solà-Soler; J A Fiz; J Morera; R Jané
Journal:  Med Biol Eng Comput       Date:  2012-03-10       Impact factor: 2.602

4.  Toward a multi-level approach to CPAP adherence.

Authors:  Alec B Platt; Nirav P Patel
Journal:  Sleep       Date:  2011-11-01       Impact factor: 5.849

5.  NREM sleep parasomnia associated with Chiari I malformation.

Authors:  Ameet S Daftary; James M Walker; Robert J Farney
Journal:  J Clin Sleep Med       Date:  2011-10-15       Impact factor: 4.062

Review 6.  Restless legs syndrome: pathophysiology, clinical presentation and management.

Authors:  Claudia Trenkwalder; Walter Paulus
Journal:  Nat Rev Neurol       Date:  2010-06       Impact factor: 42.937

7.  The new AASM criteria for scoring hypopneas: impact on the apnea hypopnea index.

Authors:  Warren R Ruehland; Peter D Rochford; Fergal J O'Donoghue; Robert J Pierce; Parmjit Singh; Andrew T Thornton
Journal:  Sleep       Date:  2009-02       Impact factor: 5.849

8.  Depression, physical activity, energy consumption, and quality of life in OSA patients before and after CPAP treatment.

Authors:  C Diamanti; E Manali; M Ginieri-Coccossis; K Vougas; K Cholidou; E Markozannes; P Bakakos; I Liappas; M Alchanatis
Journal:  Sleep Breath       Date:  2013-02-06       Impact factor: 2.816

9.  Examination of pulse oximetry tracings to detect obstructive sleep apnea in patients with advanced chronic obstructive pulmonary disease.

Authors:  Adrienne S Scott; Marc A Baltzan; Norman Wolkove
Journal:  Can Respir J       Date:  2014-02-12       Impact factor: 2.409

10.  The effect of nightly nasal CPAP treatment on nocturnal hypoxemia and sleep disorders in mustard gas-injured patients.

Authors:  Ensieh Vahedi; Ali Reza Fazeli Varzaneh; Mostafa Ghanei; Shahla Afsharpaiman; Zohre Poursaleh
Journal:  Sleep Breath       Date:  2014-01-16       Impact factor: 2.816

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.